Panagora Asset Management Inc Spero Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$12.22 - $15.79 $25,771 - $33,301	-2,109 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$11.65 - $22.07 $95,809 - $181,503	-8,224 Reduced 79.59%	2,109 $41,000
Q3 2020 Nov 13, 2020	SELL	$8.96 - $14.12 $191,493 - $301,772	-21,372 Reduced 67.41%	10,333 $115,000
Q2 2020 Aug 12, 2020	BUY	$7.27 - $14.18 $125,451 - $244,690	17,256 Added 119.43%	31,705 $429,000
Q1 2020 May 14, 2020	SELL	$5.27 - $10.41 $140,097 - $276,739	-26,584 Reduced 64.79%	14,449 $115,000
Q4 2019 Feb 12, 2020	SELL	$9.46 - $12.16 $91,884 - $118,110	-9,713 Reduced 19.14%	41,033 $394,000
Q3 2019 Nov 12, 2019	BUY	$9.01 - $12.55 $455,752 - $634,816	50,583 Added 31032.52%	50,746 $538,000
Q2 2019 Aug 09, 2019	BUY	$10.25 - $14.36 $1,670 - $2,340	163 New	163 $2,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.